Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by Axiom Investors LLC DE

Axiom Investors LLC DE boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 171,198 shares of the company's stock after purchasing an additional 26,903 shares during the quarter. Axiom Investors LLC DE owned about 0.10% of Option Care Health worth $3,972,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of OPCH. Wellington Management Group LLP increased its stake in shares of Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after buying an additional 8,400,208 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in Option Care Health by 121.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 142,441 shares of the company's stock worth $3,305,000 after acquiring an additional 78,240 shares in the last quarter. Pictet Asset Management Holding SA increased its position in Option Care Health by 12.8% during the 4th quarter. Pictet Asset Management Holding SA now owns 32,885 shares of the company's stock valued at $763,000 after purchasing an additional 3,738 shares during the period. New Age Alpha Advisors LLC bought a new stake in shares of Option Care Health in the 4th quarter valued at about $148,000. Finally, Norges Bank purchased a new stake in Option Care Health during the fourth quarter worth $60,219,000. 98.05% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on OPCH. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research upped their price target on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of "Moderate Buy" and an average target price of $33.00.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

OPCH traded down $1.40 on Friday, reaching $33.54. 2,392,435 shares of the stock were exchanged, compared to its average volume of 1,734,150. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company's 50-day moving average price is $32.97 and its 200 day moving average price is $28.51. The firm has a market capitalization of $5.51 billion, a PE ratio of 28.18, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.